skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Progress in stem cell-derived technologies for hepatocellular carcinoma

Review

(2051) Views  (1385) Full article downloads

Authors: Rajagopal N Aravalli

Published Date May 2010 Volume 2010:3 Pages 81 - 92
DOI: http://dx.doi.org/10.2147/SCCAA.S6886

Rajagopal N Aravalli

Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, USA

Abstract: Primary hepatocellular carcinoma (HCC) is a common malignancy that has a poor prognosis because it is often diagnosed at an advanced stage. HCC normally develops as a consequence of underlying liver disease and is most often associated with cirrhosis. Surgical resection and liver transplantation are the current best options to treat liver cancer. However, problems associated with liver transplantation, such as shortage of donors, risk of immune rejection, and tissue damage following surgery provided the impetus for development of alternative therapies. The emerging field of stem cell therapy has raised hopes for finding curative options for liver cancer. Stem cells have the ability not only to proliferate after transplantation but also to differentiate into most mammalian cell types in vivo. In this review, progress on stem cell-derived technologies for the treatment of liver cancer is discussed.

Keywords: liver, cancer, stem cell, therapy, hepatocellular carcinoma








Readers of this article also read:

Epigenetic modifications of embryonic stem cells: current trends and relevance in developing regenerative medicine
Regeneration and adult stem cells in the human female reproductive tract
Treatment of systemic sclerosis: potential role for stem cell transplantation
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency
Induced pluripotent stem cells: advances to applications
Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations
Hepatic progenitors for liver disease: current position
Potential and clinical utility of stem cells in cardiovascular disease
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
Engraftment of donor mesenchymal stem cells in chimeric BXSB includes vascular endothelial cells and hepatocytes
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University